IBDEI09F ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4353,2)
 ;;=^46167
 ;;^UTILITY(U,$J,358.3,4354,0)
 ;;=217.^^37^334^2
 ;;^UTILITY(U,$J,358.3,4354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4354,1,4,0)
 ;;=4^Benign Neoplasm Breast
 ;;^UTILITY(U,$J,358.3,4354,1,5,0)
 ;;=5^217.
 ;;^UTILITY(U,$J,358.3,4354,2)
 ;;=^267638
 ;;^UTILITY(U,$J,358.3,4355,0)
 ;;=617.9^^37^334^15
 ;;^UTILITY(U,$J,358.3,4355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4355,1,4,0)
 ;;=4^Endometriosis
 ;;^UTILITY(U,$J,358.3,4355,1,5,0)
 ;;=5^617.9
 ;;^UTILITY(U,$J,358.3,4355,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,4356,0)
 ;;=618.6^^37^334^16
 ;;^UTILITY(U,$J,358.3,4356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4356,1,4,0)
 ;;=4^Enterocele,Vaginal
 ;;^UTILITY(U,$J,358.3,4356,1,5,0)
 ;;=5^618.6
 ;;^UTILITY(U,$J,358.3,4356,2)
 ;;=^56796
 ;;^UTILITY(U,$J,358.3,4357,0)
 ;;=625.6^^37^334^20
 ;;^UTILITY(U,$J,358.3,4357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4357,1,4,0)
 ;;=4^Incontin,Female Stress
 ;;^UTILITY(U,$J,358.3,4357,1,5,0)
 ;;=5^625.6
 ;;^UTILITY(U,$J,358.3,4357,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,4358,0)
 ;;=611.72^^37^334^21
 ;;^UTILITY(U,$J,358.3,4358,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4358,1,4,0)
 ;;=4^Lump/Mass In Breast
 ;;^UTILITY(U,$J,358.3,4358,1,5,0)
 ;;=5^611.72
 ;;^UTILITY(U,$J,358.3,4358,2)
 ;;=Lump/Mass in Breast^72018
 ;;^UTILITY(U,$J,358.3,4359,0)
 ;;=795.00^^37^334^1
 ;;^UTILITY(U,$J,358.3,4359,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4359,1,4,0)
 ;;=4^Abnormal Pap Smear, Nos
 ;;^UTILITY(U,$J,358.3,4359,1,5,0)
 ;;=5^795.00
 ;;^UTILITY(U,$J,358.3,4359,2)
 ;;=Abnormal Pap Smear, NOS^117041
 ;;^UTILITY(U,$J,358.3,4360,0)
 ;;=618.00^^37^334^29
 ;;^UTILITY(U,$J,358.3,4360,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4360,1,4,0)
 ;;=4^Vaginal Wall Prolpse Nos
 ;;^UTILITY(U,$J,358.3,4360,1,5,0)
 ;;=5^618.00
 ;;^UTILITY(U,$J,358.3,4360,2)
 ;;=^331533
 ;;^UTILITY(U,$J,358.3,4361,0)
 ;;=611.89^^37^334^19
 ;;^UTILITY(U,$J,358.3,4361,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4361,1,4,0)
 ;;=4^Hematoma,Breast
 ;;^UTILITY(U,$J,358.3,4361,1,5,0)
 ;;=5^611.89
 ;;^UTILITY(U,$J,358.3,4361,2)
 ;;=^336616
 ;;^UTILITY(U,$J,358.3,4362,0)
 ;;=173.51^^37^334^10
 ;;^UTILITY(U,$J,358.3,4362,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4362,1,4,0)
 ;;=4^Cancer, Skin Of Breast
 ;;^UTILITY(U,$J,358.3,4362,1,5,0)
 ;;=5^173.51
 ;;^UTILITY(U,$J,358.3,4362,2)
 ;;=^340479
 ;;^UTILITY(U,$J,358.3,4363,0)
 ;;=175.9^^37^335^1
 ;;^UTILITY(U,$J,358.3,4363,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4363,1,4,0)
 ;;=4^Ca, Male Breast
 ;;^UTILITY(U,$J,358.3,4363,1,5,0)
 ;;=5^175.9
 ;;^UTILITY(U,$J,358.3,4363,2)
 ;;=CA, Male Breast^267205
 ;;^UTILITY(U,$J,358.3,4364,0)
 ;;=175.0^^37^335^2
 ;;^UTILITY(U,$J,358.3,4364,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4364,1,4,0)
 ;;=4^Ca, Male Nipple
 ;;^UTILITY(U,$J,358.3,4364,1,5,0)
 ;;=5^175.0
 ;;^UTILITY(U,$J,358.3,4364,2)
 ;;=CA, Male Nipple^267204
 ;;^UTILITY(U,$J,358.3,4365,0)
 ;;=611.1^^37^335^3
 ;;^UTILITY(U,$J,358.3,4365,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4365,1,4,0)
 ;;=4^Gynecomastia,Male
 ;;^UTILITY(U,$J,358.3,4365,1,5,0)
 ;;=5^611.1
 ;;^UTILITY(U,$J,358.3,4365,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,4366,0)
 ;;=216.0^^37^336^4
 ;;^UTILITY(U,$J,358.3,4366,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4366,1,4,0)
 ;;=4^Benign Lesion, Lip
 ;;^UTILITY(U,$J,358.3,4366,1,5,0)
 ;;=5^216.0
 ;;^UTILITY(U,$J,358.3,4366,2)
 ;;=Benign Neoplasm of Skin of Lip^267629
 ;;^UTILITY(U,$J,358.3,4367,0)
 ;;=216.1^^37^336^2
 ;;^UTILITY(U,$J,358.3,4367,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4367,1,4,0)
 ;;=4^Benign Lesion, Eyelid
